India Animal Health Market Size, Share & Trends Analysis Report By Product, By Animal (Production Animal, Companion Animal), By Distribution Channel (Retail, E-Commerce, Hospital/ Clinic Pharmacy), By End Use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
India Animal Health Market Growth & Trends
The India animal health market size is expected treach USD 4.3 billion by 2030, registering a CAGR of 12.35% from 2024 t2030, according ta new report by Grand View Research, Inc. The crucial drivers of this market is the growing startup culture and increasing government support for startup sector in the country’s animal health industry.
In the recent years, there has been an uprising of startups in the country across multiple sectors such as human healthcare, e-commerce, agriculture, animal health, and IT. The animal health industry is alsnot a stranger tthis rising number of startups which are aimed at improving diagnostic as well as treatment practices for the various animal species such as dogs, cats, cattle, poultry, swine, etc. These companies are proving tbe disruptive in innovating novel ways ttackle hurdles in the animal health industry. For instance, in January 2024, a Jaipur-based startup, Verdant Impact was launched. The company provides telemedicine access tlivestock farmers, helping them tdiagnose and treat their animals remotely. The platform connects farmers with veterinarians and animal health experts, enabling them treceive timely and accurate advice. This reduces the need for physical visits, saving time and resources for farmers. Verdant Impact aims timprove livestock health and productivity, while alsincreasing farmers' incomes. The startup has alspartnered with various organizations texpand its reach and impact.
Furthermore, in February 2024, a new startup, known as The Pet Journey, which manufactures raw dog food. The company has large product portfoliof raw dog food products which a manufactured by human-grade ingredients and with an aim tprovide customized dog food for every species of dogs. Moreover, a February 2024 article by Indian Startup Times, listed top 20 startups from various sectors that are crucial in transforming the animal health industry in the country. Some of the latest startup companies include Pawfect Pets - offers pet grooming and boarding services; PetSutra - a pet food and accessories e-commerce platform; and Vetic - veterinary telemedicine platform. Many more such startups are emerging rapidly in the country, acting as crucial driving factor for the industry.
By utilizing innovative methods and innovative techniques, these businesses are improving the accessibility and expenditures of animal healthcare services while alsenhancing diagnostic and treatment procedures. It is anticipated that this will improve the productivity and health of cattle, raising farmer earnings and stimulating the economy as a whole. The industry's growth and development is likely tbe further accelerated as it continues tinnovate and attracts in additional skills, investments, and collaborations.
Additionally, this startup culture and ultimately the market is alsboosted by various boosting activities by the government as well as other industry participants. For instance, The Centre for Cellular and Molecular platform (CCAMP) and Biotechnology Industry Research Assistance Council (BIRAC) conducts an annual competition tboost innovation in the country, known as National Bio-Entrepreneurship Competition. More than 3000 ideas are submitted every year and a handful are selected based on their merit taddress various challenges in the sectors such as biotechnology, animal health, IT, agriculture, aquaculture, life sciences, among others. The winners of the competition receive funding, mentorship, and other resources which will assist them tscale and commercialize their projects.
Furthermore, in June 2024, the Guru Angad Dev Veterinary and Animal Sciences University (GADVASU) launched a startup challenge, Start-up Punjab, with an aim tencourage entrepreneurship in the animal health sector. The challenge is open tentrepreneurs from across the country, and participants will have the opportunity tshowcase their innovative ideas and solutions. The winners will receive funding, mentorship, and incubation support thelp them develop their projects. Such initiatives foster a supportive ecosystem for startups and drive the startup culture in India, leading tinnovative solutions, job creation, and economic growth, ultimately transforming the animal health industry in the country.
India Animal Health Market Report Highlights
India Animal Health Market Growth & Trends
The India animal health market size is expected treach USD 4.3 billion by 2030, registering a CAGR of 12.35% from 2024 t2030, according ta new report by Grand View Research, Inc. The crucial drivers of this market is the growing startup culture and increasing government support for startup sector in the country’s animal health industry.
In the recent years, there has been an uprising of startups in the country across multiple sectors such as human healthcare, e-commerce, agriculture, animal health, and IT. The animal health industry is alsnot a stranger tthis rising number of startups which are aimed at improving diagnostic as well as treatment practices for the various animal species such as dogs, cats, cattle, poultry, swine, etc. These companies are proving tbe disruptive in innovating novel ways ttackle hurdles in the animal health industry. For instance, in January 2024, a Jaipur-based startup, Verdant Impact was launched. The company provides telemedicine access tlivestock farmers, helping them tdiagnose and treat their animals remotely. The platform connects farmers with veterinarians and animal health experts, enabling them treceive timely and accurate advice. This reduces the need for physical visits, saving time and resources for farmers. Verdant Impact aims timprove livestock health and productivity, while alsincreasing farmers' incomes. The startup has alspartnered with various organizations texpand its reach and impact.
Furthermore, in February 2024, a new startup, known as The Pet Journey, which manufactures raw dog food. The company has large product portfoliof raw dog food products which a manufactured by human-grade ingredients and with an aim tprovide customized dog food for every species of dogs. Moreover, a February 2024 article by Indian Startup Times, listed top 20 startups from various sectors that are crucial in transforming the animal health industry in the country. Some of the latest startup companies include Pawfect Pets - offers pet grooming and boarding services; PetSutra - a pet food and accessories e-commerce platform; and Vetic - veterinary telemedicine platform. Many more such startups are emerging rapidly in the country, acting as crucial driving factor for the industry.
By utilizing innovative methods and innovative techniques, these businesses are improving the accessibility and expenditures of animal healthcare services while alsenhancing diagnostic and treatment procedures. It is anticipated that this will improve the productivity and health of cattle, raising farmer earnings and stimulating the economy as a whole. The industry's growth and development is likely tbe further accelerated as it continues tinnovate and attracts in additional skills, investments, and collaborations.
Additionally, this startup culture and ultimately the market is alsboosted by various boosting activities by the government as well as other industry participants. For instance, The Centre for Cellular and Molecular platform (CCAMP) and Biotechnology Industry Research Assistance Council (BIRAC) conducts an annual competition tboost innovation in the country, known as National Bio-Entrepreneurship Competition. More than 3000 ideas are submitted every year and a handful are selected based on their merit taddress various challenges in the sectors such as biotechnology, animal health, IT, agriculture, aquaculture, life sciences, among others. The winners of the competition receive funding, mentorship, and other resources which will assist them tscale and commercialize their projects.
Furthermore, in June 2024, the Guru Angad Dev Veterinary and Animal Sciences University (GADVASU) launched a startup challenge, Start-up Punjab, with an aim tencourage entrepreneurship in the animal health sector. The challenge is open tentrepreneurs from across the country, and participants will have the opportunity tshowcase their innovative ideas and solutions. The winners will receive funding, mentorship, and incubation support thelp them develop their projects. Such initiatives foster a supportive ecosystem for startups and drive the startup culture in India, leading tinnovative solutions, job creation, and economic growth, ultimately transforming the animal health industry in the country.
India Animal Health Market Report Highlights
- Based on product, the pharmaceuticals segment accounted for the largest revenue share of 42.96% in 2023. The pharmaceuticals segment is further classified intparasiticide, anti-infective, anti-inflammatory, analgesics, and others. The segment’s dominance which can be attributed tincreasing prevalence of food-borne diseases, brucellosis, and zoonotic diseases that are potentially hazardous tanimals, thus, leading tclinical urgency for use of potent pharmaceuticals and targeted medicines.
- Based on animal, the production animal segment dominated the market with a revenue share of 83.04% in 2023. The significant market share represented by the segment may be attributed ta global increase in government’s attention on increasing production of animal-derived products, food safety and sustainability.
- Based on distribution channel, the hospital/clinic pharmacy segment dominated the market with a revenue share of 57.46% in 2023. The substantial share can be attributed thigh accessibility and affordability. Furthermore, hospitals provide advanced treatment products, which is expected tcontribute tthe overall growth of the hospital segment. The rise in the adoption of companion pets worldwide is driving the segment growth. Besides, high procedural volume as a consequence of frequent readmission of pets for treatment is one of the factors responsible for growth.
- Based on end use, the veterinary hospitals & clinics segment dominated the with a revenue share of 72.12% in 2023. Presence of in-house laboratories in the veterinary hospitals and clinics is enabling faster diagnosis, helping patients avail treatment at the earliest. In addition, results of the clinical tests are easily available, which reduces the delay. Furthermore, the number of visits and time consumed in taking pet patients from one place tanother is alssaved. Thus, this segment is anticipated texhibit considerable growth over the forecast period.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Brazil Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. INDIA ANIMAL HEALTH MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Government Participation
3.2.1.2. Rising Product/ Service Launches
3.2.1.3. Evolving Regulatory Scenario
3.2.1.4. Emergence of Startup Culture
3.2.1.5. Increasing R&D Investments
3.2.1.6. Technological Advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Shortage of Veterinary Institutions
3.2.2.2. Emergence of Possible Side Effects of Veterinary Drugs
3.2.2.3. High Cost of Animal Health
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. India Animal Health Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Species, 2018-2023
3.3.5. Regulatory Scenario Analysis
3.3.6. Startup Analysis
3.3.7. Pricing Analysis
3.3.8. COVID-19 Impact Analysis
CHAPTER 4. INDIA ANIMAL HEALTH MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. India Animal Health Market: Product Movement Analysis
4.3. India Animal Health Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
4.4. Biologics
4.4.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Vaccines
4.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Modified/Attenuated Live
4.4.2.2.1. Modified/Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Inactivated (Killed)
4.4.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Other Vaccines
4.4.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Other Biologics
4.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Parasiticides
4.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Anti-infectives
4.5.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Anti-inflammatory
4.5.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Analgesics
4.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.6. Other Pharmaceuticals
4.5.6.1. Other Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Diagnostics
4.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Consumables, Reagents And Kits
4.6.2.1. Consumables, Reagents And Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Instruments And Devices
4.6.3.1. Instruments And Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Equipment & Disposables
4.7.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2. Critical Care Consumables
4.7.2.1. Critical Care Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.3. Anesthesia Equipment
4.7.3.1. Anesthesia Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4. Fluid Management Equipment
4.7.4.1. Fluid Management Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5. Temperature Management Equipment
4.7.5.1. Temperature Management Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.6. Rescue & Resuscitation Equipment
4.7.6.1. Rescue & Resuscitation Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.7. Research Equipment
4.7.7.1. Research Equipments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.8. Patient Monitoring Equipment
4.7.8.1. Patient Monitoring Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Medicinal Feed Additives
4.8.1. Medicinal Feed Additives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Other Products
4.9.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.2. Veterinary Telehealth
4.9.2.1. Veterinary Telehealth Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.3. Veterinary Software
4.9.3.1. Veterinary Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.4. Livestock Monitoring
4.9.4.1. Livestock Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. INDIA ANIMAL HEALTH MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. India Animal Health Market: Animal Movement Analysis
5.3. India Animal Health Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
5.4. Production Animals
5.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Poultry
5.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Swine
5.4.3.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Cattle
5.4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Sheep & Goats
5.4.5.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Fish
5.4.6.1. Fish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Companion Animals
5.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Dogs
5.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Cats
5.5.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Horses
5.5.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.5. Other Companion Animals
5.5.5.1. Other Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. INDIA ANIMAL HEALTH MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. India Animal Health Market: Distribution Channel Movement Analysis
6.3. India Animal Health Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
6.4. Retail
6.4.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. E-commerce
6.5.1. E-commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Hospital/Clinic Pharmacy
6.6.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. INDIA ANIMAL HEALTH MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. India Animal Health Market: End use Movement Analysis
7.3. India Animal Health Market Size & Trend Analysis, by end-use, 2018 to 2030 (USD Million)
7.4. Veterinary Reference Laboratories
7.4.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Point-of-care Testing/In-house Testing
7.5.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Veterinary Hospitals & Clinics
7.6.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others end use
7.7.1. Others end use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co. Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Ceva
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Vetoquinol S.A.
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Zoetis
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boehringer Ingelheim International GmbH
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Elanco Animal Health Inc.
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Idexx Laboratories Inc.
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Neogen Corporation
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Virbac
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. B. Braun Vet Care
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Covetrus Inc.
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Avante Animal Health
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. TeleVet
8.3.13.1. Participant’s Overview
8.3.13.2. Financial Performance
8.3.13.3. Product Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Practo
8.3.14.1. Participant’s Overview
8.3.14.2. Financial Performance
8.3.14.3. Product Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Mars Inc.
8.3.15.1. Participant’s Overview
8.3.15.2. Financial Performance
8.3.15.3. Product Benchmarking
8.3.15.4. Strategic Initiatives
8.3.16. Phibro Animal Health Corporation
8.3.16.1. Participant’s Overview
8.3.16.2. Financial Performance
8.3.16.3. Product Benchmarking
8.3.16.4. Strategic Initiatives
8.3.17. Dechra Pharmaceuticals Plc
8.3.17.1. Participant’s Overview
8.3.17.2. Financial Performance
8.3.17.3. Product Benchmarking
8.3.17.4. Strategic Initiatives
8.3.18. Bimeda Inc.
8.3.18.1. Participant’s Overview
8.3.18.2. Financial Performance
8.3.18.3. Product Benchmarking
8.3.18.4. Strategic Initiatives
8.3.19. Midmark Corporation
8.3.19.1. Participant’s Overview
8.3.19.2. Financial Performance
8.3.19.3. Product Benchmarking
8.3.19.4. Strategic Initiatives
8.3.20. Thermo Fisher Scientific
8.3.20.1. Participant’s Overview
8.3.20.2. Financial Performance
8.3.20.3. Product Benchmarking
8.3.20.4. Strategic Initiatives
8.3.21. IDVet
8.3.21.1. Participant’s Overview
8.3.21.2. Financial Performance
8.3.21.3. Product Benchmarking
8.3.21.4. Strategic Initiatives
8.3.22. Hester Biosciences Ltd.
8.3.22.1. Participant’s Overview
8.3.22.2. Financial Performance
8.3.22.3. Product Benchmarking
8.3.22.4. Strategic Initiatives
8.3.23. India Immunologicals Ltd.
8.3.23.1. Participant’s Overview
8.3.23.2. Financial Performance
8.3.23.3. Product Benchmarking
8.3.23.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Expansion
8.4.4. Product launch
8.4.5. Product Approval
8.4.6. Others
8.5. List of Key Companies
8.5.1. List of Manufacturers
8.5.2. List of Distributors
8.5.3. List of Service Providers
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Brazil Market: CAGR Calculation
1.8. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. INDIA ANIMAL HEALTH MARKET VARIABLE TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Government Participation
3.2.1.2. Rising Product/ Service Launches
3.2.1.3. Evolving Regulatory Scenario
3.2.1.4. Emergence of Startup Culture
3.2.1.5. Increasing R&D Investments
3.2.1.6. Technological Advancements
3.2.2. Market Restraint Analysis
3.2.2.1. Shortage of Veterinary Institutions
3.2.2.2. Emergence of Possible Side Effects of Veterinary Drugs
3.2.2.3. High Cost of Animal Health
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. India Animal Health Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Species, 2018-2023
3.3.5. Regulatory Scenario Analysis
3.3.6. Startup Analysis
3.3.7. Pricing Analysis
3.3.8. COVID-19 Impact Analysis
CHAPTER 4. INDIA ANIMAL HEALTH MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. India Animal Health Market: Product Movement Analysis
4.3. India Animal Health Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
4.4. Biologics
4.4.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Vaccines
4.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Modified/Attenuated Live
4.4.2.2.1. Modified/Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Inactivated (Killed)
4.4.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Other Vaccines
4.4.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Other Biologics
4.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Parasiticides
4.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Anti-infectives
4.5.3.1. Anti-infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Anti-inflammatory
4.5.4.1. Anti-inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Analgesics
4.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.6. Other Pharmaceuticals
4.5.6.1. Other Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Diagnostics
4.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Consumables, Reagents And Kits
4.6.2.1. Consumables, Reagents And Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Instruments And Devices
4.6.3.1. Instruments And Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Equipment & Disposables
4.7.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.2. Critical Care Consumables
4.7.2.1. Critical Care Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.3. Anesthesia Equipment
4.7.3.1. Anesthesia Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.4. Fluid Management Equipment
4.7.4.1. Fluid Management Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.5. Temperature Management Equipment
4.7.5.1. Temperature Management Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.6. Rescue & Resuscitation Equipment
4.7.6.1. Rescue & Resuscitation Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.7. Research Equipment
4.7.7.1. Research Equipments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7.8. Patient Monitoring Equipment
4.7.8.1. Patient Monitoring Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Medicinal Feed Additives
4.8.1. Medicinal Feed Additives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Other Products
4.9.1. Other Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.2. Veterinary Telehealth
4.9.2.1. Veterinary Telehealth Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.3. Veterinary Software
4.9.3.1. Veterinary Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9.4. Livestock Monitoring
4.9.4.1. Livestock Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. INDIA ANIMAL HEALTH MARKET: ANIMAL ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. India Animal Health Market: Animal Movement Analysis
5.3. India Animal Health Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
5.4. Production Animals
5.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Poultry
5.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Swine
5.4.3.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Cattle
5.4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Sheep & Goats
5.4.5.1. Sheep & Goats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Fish
5.4.6.1. Fish Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Companion Animals
5.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Dogs
5.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Cats
5.5.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Horses
5.5.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.5. Other Companion Animals
5.5.5.1. Other Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. INDIA ANIMAL HEALTH MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. India Animal Health Market: Distribution Channel Movement Analysis
6.3. India Animal Health Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
6.4. Retail
6.4.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. E-commerce
6.5.1. E-commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Hospital/Clinic Pharmacy
6.6.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. INDIA ANIMAL HEALTH MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. India Animal Health Market: End use Movement Analysis
7.3. India Animal Health Market Size & Trend Analysis, by end-use, 2018 to 2030 (USD Million)
7.4. Veterinary Reference Laboratories
7.4.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Point-of-care Testing/In-house Testing
7.5.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Veterinary Hospitals & Clinics
7.6.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others end use
7.7.1. Others end use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co. Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Ceva
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Vetoquinol S.A.
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Zoetis
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boehringer Ingelheim International GmbH
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Elanco Animal Health Inc.
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Idexx Laboratories Inc.
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Neogen Corporation
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Virbac
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. B. Braun Vet Care
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Covetrus Inc.
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Avante Animal Health
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. TeleVet
8.3.13.1. Participant’s Overview
8.3.13.2. Financial Performance
8.3.13.3. Product Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Practo
8.3.14.1. Participant’s Overview
8.3.14.2. Financial Performance
8.3.14.3. Product Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Mars Inc.
8.3.15.1. Participant’s Overview
8.3.15.2. Financial Performance
8.3.15.3. Product Benchmarking
8.3.15.4. Strategic Initiatives
8.3.16. Phibro Animal Health Corporation
8.3.16.1. Participant’s Overview
8.3.16.2. Financial Performance
8.3.16.3. Product Benchmarking
8.3.16.4. Strategic Initiatives
8.3.17. Dechra Pharmaceuticals Plc
8.3.17.1. Participant’s Overview
8.3.17.2. Financial Performance
8.3.17.3. Product Benchmarking
8.3.17.4. Strategic Initiatives
8.3.18. Bimeda Inc.
8.3.18.1. Participant’s Overview
8.3.18.2. Financial Performance
8.3.18.3. Product Benchmarking
8.3.18.4. Strategic Initiatives
8.3.19. Midmark Corporation
8.3.19.1. Participant’s Overview
8.3.19.2. Financial Performance
8.3.19.3. Product Benchmarking
8.3.19.4. Strategic Initiatives
8.3.20. Thermo Fisher Scientific
8.3.20.1. Participant’s Overview
8.3.20.2. Financial Performance
8.3.20.3. Product Benchmarking
8.3.20.4. Strategic Initiatives
8.3.21. IDVet
8.3.21.1. Participant’s Overview
8.3.21.2. Financial Performance
8.3.21.3. Product Benchmarking
8.3.21.4. Strategic Initiatives
8.3.22. Hester Biosciences Ltd.
8.3.22.1. Participant’s Overview
8.3.22.2. Financial Performance
8.3.22.3. Product Benchmarking
8.3.22.4. Strategic Initiatives
8.3.23. India Immunologicals Ltd.
8.3.23.1. Participant’s Overview
8.3.23.2. Financial Performance
8.3.23.3. Product Benchmarking
8.3.23.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Expansion
8.4.4. Product launch
8.4.5. Product Approval
8.4.6. Others
8.5. List of Key Companies
8.5.1. List of Manufacturers
8.5.2. List of Distributors
8.5.3. List of Service Providers
